{
    "ticker": "EVH",
    "name": "Evofem Biosciences, Inc.",
    "description": "Evofem Biosciences, Inc. is a biotechnology company focused on developing and commercializing innovative products for women's sexual and reproductive health. Founded in 2008 and headquartered in San Diego, California, Evofem is dedicated to advancing women's health through novel solutions that empower women to take control of their reproductive choices. The company's flagship product, Phexxi, is a hormone-free contraceptive gel that offers women an alternative to traditional birth control methods. Phexxi works by maintaining vaginal pH within an optimal range to prevent sperm from reaching an egg. This groundbreaking approach to contraception has garnered attention for its unique mechanism of action and its potential to improve adherence among women who may be averse to hormonal options. Evofem is committed to addressing the unmet needs of women and is also exploring additional indications for its technologies, including sexually transmitted infection prevention. With a strong focus on research and development, Evofem aims to expand its product pipeline to deliver more innovative health solutions for women globally.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2008",
    "website": "https://www.evofem.com",
    "ceo": "Saundra Pelletier",
    "social_media": {
        "twitter": "https://twitter.com/evofembiosci",
        "linkedin": "https://www.linkedin.com/company/evofem-biosciences"
    },
    "investor_relations": "https://ir.evofem.com",
    "key_executives": [
        {
            "name": "Saundra Pelletier",
            "position": "CEO"
        },
        {
            "name": "William G. Gruber",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Contraceptive Products",
            "products": [
                "Phexxi"
            ]
        }
    ],
    "seo": {
        "meta_title": "Evofem Biosciences, Inc. | Women's Health and Innovative Contraception",
        "meta_description": "Evofem Biosciences, Inc. focuses on women's sexual and reproductive health, developing innovative products like Phexxi, a hormone-free contraceptive gel.",
        "keywords": [
            "Evofem",
            "Women's Health",
            "Contraception",
            "Phexxi",
            "Biotechnology"
        ]
    },
    "faq": [
        {
            "question": "What is Evofem known for?",
            "answer": "Evofem is known for its innovative contraceptive product Phexxi and its focus on women's sexual and reproductive health."
        },
        {
            "question": "Who is the CEO of Evofem?",
            "answer": "Saundra Pelletier is the CEO of Evofem Biosciences, Inc."
        },
        {
            "question": "Where is Evofem headquartered?",
            "answer": "Evofem is headquartered in San Diego, California, USA."
        },
        {
            "question": "What is Phexxi?",
            "answer": "Phexxi is a hormone-free contraceptive gel that maintains vaginal pH to prevent sperm from reaching an egg."
        },
        {
            "question": "When was Evofem founded?",
            "answer": "Evofem was founded in 2008."
        }
    ],
    "competitors": [
        "BHC",
        "BMY",
        "PDCO",
        "MYOV"
    ],
    "related_stocks": [
        "JNJ",
        "PFE",
        "MRNA",
        "ABBV"
    ]
}